{"schema_version":"secwatch.filing_event.v1","accession":"0001478242-24-000113","form_type":"8-K","ticker":"IQV","cik":"0001478242","company_name":"IQVIA HOLDINGS INC.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.550749+00:00","generated_at":"2026-05-30T07:23:08.196193+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"IQVIA Q3 revenue $3,896M, Adj EPS $2.84 (+14.1%); FY24 guidance cut on trial delays","bullets":["Q3 revenue $3,896M (+4.3% YoY); GAAP EPS $1.55; Adj EPS $2.84 (+14.1%).","R&D Solutions backlog $31.1B (+8% YoY); book-to-bill 1.22x TTM (excl. cancellation).","TAS revenue $1,554M (+8.6% YoY), accelerating from prior quarters.","FY24 guidance lowered: rev $15,350-15,400M; Adj EPS $11.10-11.20 due to two mega trial delays.","Operating cash flow YTD $1,831M (+31% YoY); FCF $1,393M (+49% YoY); $200M share buyback in Q3."],"urls":{"canonical":"https://secwatch.observer/filing/0001478242-24-000113","json":"https://secwatch.observer/filing/0001478242-24-000113.json","markdown":"https://secwatch.observer/filing/0001478242-24-000113.md","text":"https://secwatch.observer/filing/0001478242-24-000113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1478242/000147824224000113/0001478242-24-000113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1478242/000147824224000113/iqv-20241031.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:23:08.196193+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}